MEDICLIN Aktiengesellschaft (ETR:MED)
Germany · Delayed Price · Currency is EUR 5.80
+0.20 (3.57%)
Sep 16, 2026, 3:41 PM CET
ETR:MED Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 266 | 176 | 115 | 130 | 171 | 186 | |
Market Cap Growth | 91.78% | 52.89% | -11.68% | -23.89% | -8.16% | 1.03% |
Enterprise Value | 572 | 507 | 462 | 507 | 477 | 526 |
Last Close Price | 5.60 | 3.66 | 2.36 | 2.67 | 3.51 | 3.83 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.14 | 6.90 | 4.63 | - | 18.11 | 127.41 |
Forward PE | 7.27 | 7.29 | 6.45 | 7.41 | 13.09 | 49.00 |
PS Ratio | 0.32 | 0.22 | 0.15 | 0.17 | 0.24 | 0.27 |
PB Ratio | 1.02 | 0.70 | 0.52 | 0.66 | 0.82 | 1.02 |
P/TBV Ratio | 1.10 | 0.75 | 0.58 | 0.75 | 1.10 | 1.46 |
P/FCF Ratio | 4.75 | 3.25 | 2.70 | 2.99 | 16.65 | 2.79 |
P/OCF Ratio | 2.72 | 1.72 | 1.43 | 1.67 | 4.94 | 2.27 |
PEG Ratio | - | 2.29 | 2.29 | 2.29 | 2.29 | 2.29 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.70 | 0.63 | 0.61 | 0.67 | 0.66 | 0.77 |
EV/EBITDA Ratio | 4.85 | 6.14 | 6.43 | 7.60 | 12.91 | 17.99 |
EV/EBIT Ratio | 8.86 | 8.42 | 9.15 | 12.14 | 46.12 | 186.12 |
EV/FCF Ratio | 10.22 | 9.38 | 10.87 | 11.63 | 46.44 | 7.88 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.47 | 1.57 | 2.08 | 2.45 | 2.40 | 2.40 |
Debt / EBITDA Ratio | 3.25 | 3.47 | 4.61 | 5.10 | 6.15 | 5.75 |
Debt / FCF Ratio | 6.83 | 7.24 | 10.92 | 11.01 | 48.95 | 6.59 |
Net Debt / Equity Ratio | 1.17 | 1.24 | 1.57 | 1.86 | 1.98 | 1.75 |
Net Debt / EBITDA Ratio | 3.47 | 3.74 | 4.85 | 5.47 | 11.23 | 10.96 |
Net Debt / FCF Ratio | 5.45 | 5.71 | 8.20 | 8.36 | 40.38 | 4.80 |
Asset Turnover | 0.94 | 0.92 | 0.85 | 0.85 | 0.80 | 0.77 |
Inventory Turnover | 100.70 | 96.49 | 82.28 | 74.16 | 67.62 | 62.90 |
Quick Ratio | 1.09 | 1.50 | 1.73 | 1.84 | 1.39 | 1.14 |
Current Ratio | 1.77 | 1.68 | 1.79 | 2.05 | 1.53 | 1.25 |
Return on Equity (ROE) | 11.93% | 10.97% | 11.90% | -5.29% | 4.95% | 0.83% |
Return on Assets (ROA) | 4.61% | 4.31% | 3.53% | 2.90% | 0.72% | 0.20% |
Return on Invested Capital (ROIC) | 8.28% | 7.84% | 6.92% | 7.05% | 1.82% | 0.32% |
Return on Capital Employed (ROCE) | 9.50% | 9.00% | 6.80% | 5.70% | 1.40% | 0.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 10.94% | 14.50% | 21.61% | -8.28% | 5.52% | 0.78% |
FCF Yield | 21.04% | 30.73% | 36.99% | 33.49% | 6.00% | 35.84% |
Dividend Yield | 0.73% | 1.09% | 1.69% | - | - | - |
Payout Ratio | 6.53% | 7.46% | - | - | - | - |
Total Shareholder Return | 0.73% | 1.09% | 1.69% | - | - | - |